Curing more cervical cancer cases may be in the math

Jan 29, 2010

Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.

Quicker identification of non-responding tumors may be possible using a new mathematical model developed by researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

The model uses information from (MRI) scans taken before and during therapy to monitor changes in tumor size. That information is plugged into the model to predict whether a particular case is responding well to treatment. If not, the patient can be changed to a more aggressive or experimental therapy midway through treatment, something not possible now.

The study, published in the journal Cancer Research, uses MRI scans and outcome information from 80 patients receiving a standard course of designed to cure their cancer.

"The model enables us to better interpret clinical data and predict treatment outcomes for individual patients," says principal investigator Jian Z. Wang, assistant professor of radiation medicine and a radiation physicist at the James Cancer Hospital and Solove Research Institute.

"The outcome predictions presented in this paper were solely based on changes in tumor volume as derived from MRI scans, which can be easily accessed even in community hospitals," Wang says. "The model is very robust and can provide a prediction accuracy of 90 percent for local tumor control and recurrence."

A strength of the new model, says first author Zhibin Huang, is its use of MRI data to estimate three factors that play key roles in tumor shrinkage and that vary from patient to patient - the proportion of tumor cells that survive , the speed at which the body removes dead cells from the tumor, and the growth rate of surviving .

The model is applicable to all cervical cancer patients, and the investigators are developing a model that can be applied to other cancer sites, Wang says.

Coauthor Dr. Nina A. Mayr, professor of radiation medicine at Ohio State, notes that the size of cervical tumors is currently estimated by touch, or palpation, which is often imprecise. Furthermore, shrinkage of a tumor may not be apparent until months after therapy has ended.

Other clinical factors currently used to predict a tumor's response to therapy include the tumor's stage, whether it has invaded nearby lymph nodes and its microscopic appearance.

"Our kinetic model helps us understand the underlying biological mechanisms of the rather complicated living tissue that is a tumor," Wang says. "It enables us to better interpret clinical data and predict treatment outcomes, which is critical for identifying the most effective therapy for personalized medicine."

Explore further: AstraZeneca cancer drug, companion test approved

Provided by Ohio State University Medical Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Forecasting cancer recurrence

Jul 28, 2009

Two people with the same kind of cancer who receive the exact same treatment may nevertheless have different chances of their tumors coming back years later. Now a team of scientists has developed a computer model that predicts ...

Bright tumors, dim prospects

Sep 13, 2007

It doesn't matter how small or large it is, if a cervical tumor glows brightly in a PET scan, it's apt to be more dangerous than dimmer tumors. That's the conclusion of a new study of cervical cancer patients at Washington ...

Mathematical Model Predicts Factors Driving Tumor Invasion

Jul 02, 2009

Tumors are complex collections of cells whose behavior has proven difficult to understand, let alone predict. As a result, oncologists are often surprised by how a particular patient responds to a given course of therapy.

Recommended for you

Putting the brakes on cancer

16 hours ago

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

Peanut component linked to cancer spread

17 hours ago

Scientists at the University of Liverpool have found that a component of peanuts could encourage the spread and survival of cancer cells in the body.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.